Purchase Order 75D30124P00033
Award Date 6/21/24
Potential Completion Date 6/20/29
Potential Value $121K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order worth $125,096.60 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV-1 control kits. The order has an anticipated completion date of August 25, 2022 and did not utilize any set-aside designations. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously supported federal customers such as the Department of...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV RNA extraction services. The firm-fixed-price contract, valued at $90,200.00, was awarded under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has an ultimate completion date of July 31, 2018 and is not designated as a set-aside contract. Abbott Molecular is a manufacturer of molecular diagnostic...
- This federal contract award is to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The contract has a potential value of $145,589.00 and is a Delivery Order under the Critical Analyzers, Laboratory GSA Schedule contract. The contract does not have a set-aside designation. Through this award, Abbott...
- This federal contract award is for a yearly service agreement between the Centers for Disease Control and Prevention (CDC) and Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the Abbott Alinity M NAT System. The $160,552.75 firm fixed-price purchase order does not have a set-aside designation, reflecting Abbott's status as a large, established medical technology corporation. The contract has an ultimate completion date of June 14, 2028. Abbott Molecular Inc. is the prime...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for an estimated $100,800.00. The contract does not have a set-aside designation. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will provide unspecified "other functions" to support the CDC's operations in Atlanta, Georgia. The award is not...
- This federal contract award is for the provision of reagents and consumables for use on the Abbott M2000SP and Abbott M2000RT molecular diagnostic platforms. The $121,338.60 contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a Blanket Purchase Agreement (BPA) call order under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order valued at $122,410.61 to Abbott Molecular Inc. on September 19, 2025, for maintenance and support services of m2000 Realtime polymerase chain reaction (PCR) platforms utilized by the CDC's International Laboratory Branch. The contract, which runs through August 30, 2026, encompasses preventive and corrective maintenance, original equipment manufacturer software and firmware updates, quality...
- This federal contract award, valued at $718,564.83, was made by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is a Blanket Purchase Agreement (BPA) call for the provision of Alinity M COVID-19 testing, HIV testing, and human papillomavirus (HPV) testing supplies. The contract has a firm fixed price pricing type and a completion date of September 21,...
- This federal contract award was issued by the Veterans Integrated Service Network 21 (VISN 21), a component of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract, valued at $671,127.40, is for the provision of HIV and HCV molecular testing services and products. This award was made under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule contract, which is a Firm Fixed Price contract type. The contract does not have...
- This federal contract award was made by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $1,800,000.00 Blanket Purchase Agreement (BPA) call order is for HIV molecular Clinical Pharmacology Research Resource (CPRR) services. The contract does not have a set-aside designation. The BPA was established under the GSA Schedule 66-III contract for Critical Analyzers...